Home/Filings/4/0001415889-25-017592
4//SEC Filing

Jain Rita 4

Accession 0001415889-25-017592

CIK 0001370053other

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 6:33 PM ET

Size

9.7 KB

Accession

0001415889-25-017592

Insider Transaction Report

Form 4
Period: 2025-06-15
Jain Rita
Director
Transactions
  • Exercise/Conversion

    Restricted Stock Unit

    2025-06-156,0300 total
    Common Stock (6,030 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-06-151,3001,300 total
    Common Stock (1,300 underlying)
  • Exercise/Conversion

    Common Stock

    2025-06-15+7,33011,864 total
Footnotes (3)
  • [F1]Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
  • [F2]The RSUs shall vest as to 1/3 of the total shares on June 15, 2024, and thereafter vests as to 1/3 of the total RSUs on June 15, 2025; and as to 1/3 of the total RSUs on June 15, 2026, subject to the provision of services to the Company on each vesting date.
  • [F3]The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Issuer

ANAPTYSBIO, INC

CIK 0001370053

Entity typeother

Related Parties

1
  • filerCIK 0001707797

Filing Metadata

Form type
4
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 6:33 PM ET
Size
9.7 KB